Immuron IMRN
NASDAQ IMRN
$1.77 -0.07 (-3.80%)
As of: Sep 9, 2026 · 3:59 PM EDT

Immuron (IMRN) Profit After Tax (2016 - 2025)

Immuron (IMRN) posted Profit After Tax of -$3.3 million for Q2 2025, down 7129.21% on a QoQ basis from -$46208.3 in Q3 2024, and up 26.93% year-over-year from -$2.6 million in Q2 2024.

Analysis

Immuron (IMRN) Profit After Tax (2016 - 2025) Analysis & Trends

Immuron has reported Profit After Tax for 10 years, with the latest figure at -$3.3 million in Q2 2025.

  • On a quarterly basis, Profit After Tax rose 26.93% year-over-year to -$3.3 million in Q2 2025; TTM through Jun 2025 was -$10.4 million, a 12.91% decrease from a year earlier, with the FY2026 full-year figure at $16311.0, up 120210.46% from the prior year.
  • Profit After Tax was -$3.3 million for Q2 2025 at Immuron, down from -$46208.3 in the prior quarter.
  • The five-year high for Profit After Tax was -$13260.2 in Q4 2021, with the low at -$6.5 million in Q2 2021.
  • Average Profit After Tax over 5 years is -$2.4 million, with a median of -$2.2 million recorded in 2022.
  • The sharpest annual moves came in 2021 and 2022: Profit After Tax jumped 68.39% in 2021, then slumped 14819.74% in 2022.
  • Over 5 years, Profit After Tax stood at -$13260.2 in 2021, then plunged by 14819.74% to -$2.0 million in 2022, then slipped by 24.6% to -$2.5 million in 2023, then soared by 98.13% to -$46208.3 in 2024, then sank by 7129.21% to -$3.3 million in 2025.
  • The last three Profit After Tax figures came in at -$3.3 million (Q2 2025), -$46208.3 (Q3 2024), and -$4.6 million (Q2 2024), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn 2.38 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn -10.50 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn 1.10 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn 1.30 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn 472.00 Mn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn -782.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn 164.49 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn 97.50 Mn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn -290.61 Mn
10 Immuron 10.28 Mn 1.26 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -3.34 Mn
Sep 9, 2024 -46,208.27
Jun 30, 2024 -4.57 Mn
Dec 31, 2023 -2.46 Mn
Jun 30, 2023 -216,776.03
Dec 31, 2022 -1.98 Mn
Dec 31, 2021 -13,260.17
Jun 30, 2021 -6.46 Mn
Dec 31, 2020 -41,946.68
Jun 30, 2020 -1.92 Mn
Dec 31, 2019 -15,212.27
Dec 31, 2018 -1.58 Mn
Dec 31, 2017 -1.45 Mn
Dec 31, 2016 -2.57 Mn
Jun 30, 2016 -3.28 Mn